CN Patent

CN120192305A — 一种含苯环的多环化合物、其药物组合物及其应用

Assigned to Wuhan Xirui Pharmaceutical Technology Co ltd · Expires 2025-06-24 · 1y expired

What this patent protects

本发明公开了一种含苯环的多环化合物、其药物组合物及其应用。具体提供了一种如式(I‑D)所示的化合物或其药学上可接受的盐。本发明的化合物具有如下效果优势中的一个或多个：(1)结构新颖；(2)对NaV1.8通道活性有良好的阻滞效果；(3)对Nav其他亚型(例如Nav1.1、Nav1.2、Nav1.3Nav1.4、Nav1.5、Nav1.6、Nav1.7、Nav1.9)具有良好的选择性，安全性高。

USPTO Abstract

本发明公开了一种含苯环的多环化合物、其药物组合物及其应用。具体提供了一种如式(I‑D)所示的化合物或其药学上可接受的盐。本发明的化合物具有如下效果优势中的一个或多个：(1)结构新颖；(2)对NaV1.8通道活性有良好的阻滞效果；(3)对Nav其他亚型(例如Nav1.1、Nav1.2、Nav1.3Nav1.4、Nav1.5、Nav1.6、Nav1.7、Nav1.9)具有良好的选择性，安全性高。

Drugs covered by this patent

Patent Metadata

Patent number
CN120192305A
Jurisdiction
CN
Classification
—
Expires
2025-06-24
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Xirui Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.